the above chart is Acadia…that is a fine-looking breakout chart.
i would feel comfortable buying that stock, based on that chart.
So what is wrong with Neuren? Why is it being so pathetic lately?
Poor Acadia barely makes a profit after paying all the bills for selling its two drugs, while NEU just pockets 10-12% of the Daybue revenue before expenses plus milestones..
NEU is doing very nicely out of Daybue. Yet Acadia has the great looking chart, while a NEU's chart is sick.
makes no sense.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$14.10 |
Change
0.790(5.94%) |
Mkt cap ! $1.756B | |||
| Open | High | Low | Value | Volume |
| $13.50 | $14.21 | $12.96 | $6.579M | 476.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 460 | $14.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.11 | 932 | 11 |
View Market Depth
| Last trade - 14.31pm 27/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |